OA03.05 A Randomized, Phase 3 Study of Iruplinalkib (WX-0593) Vs Crizotinib in Locally Advanced or Metastatic ALK+ Non-small Cell Lung Cancer (NSCLC)

Y. Shi,J. Chen, R. Yang,H. Wu, Z. Wang, W. Yang, J. Cui, Y. Zhang,C. Liu, Y. Cheng,Y. Liu,J. Shan,D. Wang, L. Yang, C. Hu,J. Zhao, R. Cao, B. Tan,K. Xu, M. Si

Journal of Thoracic Oncology（2023）

Cited 1|Views24

AI Read Science

Must-Reading Tree

Example

Generate MRT to find the research sequence of this paper

Chat Paper

Summary is being generated by the instructions you defined